This is an optional event before SDBN Speed Networking February 3rd, attend both and you’ll learn and connect even more. Do you work in the area of protein degradation, or are you interested in learning […]
Do you work in the area of immuno-oncology? If so, join us for a group discussion about the current progress and challenges in the field, led by Eurofins Discovery lead scientists. Meet experts and local […]
The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and […]
San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, […]
Here at SDBN we?ve been updating our directory of 400+ San Diego biotech companies.? We were surprised to find close to 40 companies removed from the local scene ? due to acquisition or shut down.? […]
Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been […]
This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.? We are excited to attend and soak in all the science that will be […]
The first in our Virtual Biotech series, our July 19th event was a success.? Thanks to our participants ? some of San Diego?s leading virtual drug discovery scientists and CROs – for sharing their valuable […]
Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug […]
The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on […]
Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one […]
Trius Therapeutics is a great local company which recently had an initial public offering (IPO), quite a feat in this economy. What is the secret to their success? They focus on antibacterials for life threatening […]
We’re going to try something new for the San Diego Biotechnology Network in September. The folks at Halozyme have offered to start hosting events quarterly at their site in Sorrento Valley, and we’ll kick of […]
June 2010 marks the 10th anniversary of the sequencing of the human genome. As Francis Collins has pointed out, “we invariably overestimate the short-term impacts of new technologies and underestimate their longer-term effects.” As a […]
Our January Speed Networking event went so well that we promised we’d do it again so that you can meet as many local biotech professionals as possible in one night. How does it work? Check […]
The California Institute for Regenerative Medicine (CIRM) granted a local interdisciplinary research team from UCSD, Salk, and Life Technologies $11.5 million for research aimed at finding a cure for amyotrophic lateral sclerosis (ALS), or Lou […]
At the afternoon session of the Society for Biomolecular Science in Phoenix, it’s all about epigenetics, the study of heritable changes that don’t involve changes in genetic sequence. Epigenetics explains why identical twins turn out a little different and why even cloned cows will have different coloration patterns.
[…]
I went to a morning session on stem cells on day 2 of the Society for Biomolecular Science meeting in Phoenix, a meeting focused on advancements in drug discovery and screening technology.? After this, it’s […]
At the 2010 Society for Biomolecular Science meeting on Tuesday, Steve Bryant from NIH gave a report on the increasing utility of the NIH Pubchem database for pharma drug screening programs. […]
I’m blogging from the Society for Biomolecular Sciences conference in Phoenix, the organizers were kind enough to offer two of us complimentary passes. I was surprised that the sessions were separated into disease area, technique, […]
We are launching channels on the San Diego Biotechnology Network, where local scientists and biotechnology professionals will be able to blog and discuss the topic. Our first posts will be from the Society for Biomolecular […]
Copyright © 2022 Biotech Networks, LLC
